Skip to main content
. 2021 Sep 28;12:732716. doi: 10.3389/fphar.2021.732716

TABLE 1.

Significantly altered metabolites among the control and the EGCG-treated groups by ANOVA test analysis with Tukey’s post hoc analysis.

p. value Tukey’s HSD
4-Imidazoleacetic acid 4.970E-07 40 μM-0 μM; 80 μM-0 μM
Glutathione reduced 3.730E-06 40 μM-0 μM; 80 μM-0 μM
Agmatine 1.160E-05 40 μM-0 μM; 80 μM-0 μM
Cytosine 2.710E-05 40 μM-0 μM; 80 μM-0 μM
Aspartate 1.126E-04 40 μM-0 μM; 80 μM-0 μM
2-Deoxycytidine 1.900E-04 40 μM-0 μM; 80 μM-0 μM
2/3-Aminoisobutyric acid/Dimethylglycine 3.167E-04 40 μM-0 μM; 80 μM-0 μM
Proline 3.484E-04 40 μM-0 μM; 80 μM-0 μM
6-Methyl-DL-Tryptophan 4.916E-04 80-0 μM
Serine 0.001 80-0 μM
R5P 0.001 80-0 μM
2-Methylglutaric acid 0.001 40 μM-0 μM; 80 μM-0 μM
Asparagine 0.001 80-0 μM
Acetohydroxamic acid 0.002 80-0 μM

R5P, Ribose-5-phosphate.